D-0242-2021 Class III Terminated
FDA drug recall D-0242-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jan 11, 2021 and is designated Class III. Reason for recall: Incorrect Labeling: Incorrect lot number on secondary packaging The recall status is terminated (terminated Nov 2, 2021). Affected quantity: 36,275 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 3, 2021
- Initiation Date
- Jan 11, 2021
- Termination Date
- Nov 2, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 36,275 cartons
Product description
Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40
Reason for recall
Incorrect Labeling: Incorrect lot number on secondary packaging
Distribution pattern
Nationwide
Code information
Lot JKX2553A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0242-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026